Literature DB >> 2437955

Silicone oil with high specific gravity for intraocular use.

V P Gabel, A Kampik, C Gabel, D Spiegel.   

Abstract

Silicone oil with a higher specific gravity than that of intraocular fluid or polydimethylsiloxane may have special indications in vitreoretinal surgery. Trifluorsiloxane is such a substance, and therefore its biological compatibility was investigated in rabbit eyes. It was found that this substance was clinically well tolerated within the observation time of up to 6 months, even if there was some neovascularisation from the inferior limbus. Histologically both an inflammatory response and tissue impregnation were more pronounced than with normal polydimethylsiloxane.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437955      PMCID: PMC1041140          DOI: 10.1136/bjo.71.4.262

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  The use of liquid silicone in retinal detachment surgery.

Authors:  P A CIBIS; B BECKER; E OKUN; S CANAAN
Journal:  Arch Ophthalmol       Date:  1962-11

2.  Use of liquid silicone in vitrectomised eyes.

Authors:  J D Scott
Journal:  Dev Ophthalmol       Date:  1981

3.  [Liquid silicone in amotio surgery (II). Report on 280 cases - further development of the technic].

Authors:  R Zivojnović; D A Mertens; E Peperkamp
Journal:  Klin Monbl Augenheilkd       Date:  1982-12       Impact factor: 0.700

4.  Silicone retinopiesis for retinal detachment. A long-term clinical evaluation.

Authors:  R C Watzke
Journal:  Arch Ophthalmol       Date:  1967-02
  4 in total
  16 in total

1.  Fluorosilicone oil for retinal detachment.

Authors:  J D Scott
Journal:  Br J Ophthalmol       Date:  1990-11       Impact factor: 4.638

2.  The use of silicone oil-RMN3 (Oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery.

Authors:  Louisa Wickham; Paris Tranos; Paul Hiscott; David Charteris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-27       Impact factor: 3.117

3.  Long-term heavy silicone oil intraocular tamponade.

Authors:  Ian J Dooley; Emma S Duignan; Dara J Kilmartin
Journal:  Int Ophthalmol       Date:  2015-03-27       Impact factor: 2.031

4.  Comparison of Densiron 68 and 1 000 cSt silicone oil in the management of rhegmatogenous retinal detachment with inferior breaks.

Authors:  Ibrahim Kocak; Haci Koc
Journal:  Int J Ophthalmol       Date:  2013-02-18       Impact factor: 1.779

5.  Analysis of the rates of emulsification in intraocular silicone oil tamponades of differing viscosities.

Authors:  Xiu-Juan Zhao; Ning-Ning Tang; Yu Lian; Bing-Qian Liu; Yong-Hao Li; Lin Lu
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

6.  Spontaneous resolution of macular edema after silicone oil removal.

Authors:  Eyyup Karahan; Ibrahim Tuncer; Mehmet Ozgur Zengin; Cem Kucukerdonmez; Suleyman Kaynak
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

7.  Oxane HD vs silicone oil and scleral buckle in retinal detachment with proliferative vitreoretinopathy and inferior retinal breaks.

Authors:  Francesco Boscia; Claudio Furino; Nicola Recchimurzo; Gianluca Besozzi; Giancarlo Sborgia; Carlo Sborgia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-28       Impact factor: 3.117

8.  Tamponade efficiency of perfluorohexyloctane and silicone oil solutions in a model eye chamber.

Authors:  C Wetterqvist; D Wong; R Williams; T Stappler; E Herbert; S Freeburn
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

Review 9.  The concept of heavy tamponades-chances and limitations.

Authors:  Antonia M Joussen; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117

10.  Intraocular inflammation following endotamponade with high-density silicone oil.

Authors:  Thomas Theelen; Maurits A D Tilanus; B Jeroen Klevering
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-17       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.